Deletion of the Carboxyl-Terminal Transactivation Domain

“Deletion of the Carboxyl-Terminal Transactivation Domain of MGF-Stat5 Results in Sustained DNA Binding and a Dominant Negative Phenotype”¹

1.
Moriggl R, Gouilleux-Gruart V, Jähne R, et al. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol. Published online October 1996:5691-5700. doi:10.1128/mcb.16.10.5691

Richard Moriggl PhD C-terminal
Richard Moriggl is professor for "Functional Cancer Genomics" in a joint appointment of the University for Veterinary Medicine, Vienna and the Medical University Vienna. Dr. Moriggl studied biotechnology in Germany and did his PhD in 1997 working on cytokine signaling with Prof. Groner, Friedrich Miescher Institute, Basel, Switzerland and Institute of Experimental Cancer Research, Freiburg, Germany.
Richard Moriggl has a PhD from the Friedrich Miescher Institute for Biomedical Research. Richard Moriggl PhD currently works at the University for Veterinary Medicine and has 3 years experience in researching MGF-Stat5 results at the University of Freiburg. One of their notable works include "Deletion of the Carboxyl-Terminal Transactivation Domain of MGF-Stat5 Results in Sustained DNA Binding and a Dominant Negative Phenotype". Published online October 1996. doi:https://doi.org/10.1128/mcb.16.10.5691 [PubMed]
LinkedIn | Ludwig Boltzmann Institute for Cancer Research | Ludwig Boltzmann Institute for Cancer Research